Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee ...

Before Wegovy, 190,000 people in the U.S. were claiming GLP-1 drugs ... with 5.1 percent of white patients with obesity on weight loss drugs compared to just 3.7 percent of Hispanic patients with ...

Zealand Pharma A/S said moderate doses of its experimental weight-loss drug helped patients pare pounds with less nausea than ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic ...

Catalent's revenue for fiscal first quarter ended Sept. 30 was $1.02 billion, marginally below analysts' estimates of $1.06 ...

Welcome to the healthier, happier world of 2030. Heart attacks and strokes are down 20%. A drop in food consumption has left ...

Related Ozempic, Wegovy might help ease knee arthritis pain Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity Ozempic, Wegovy might lower Alzheimer's risk in Type 2 diabetics But GLP ...

Wegovy — the weight loss version of the drug Ozempic — was approved by the U.S. Food and Drug Administration in 2021. It was ...

As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their ...

The results come as those drugs, like Wegovy and Ozempic, explode in popularity, leading to shortages as well as greater competition. Executives on Monday said those supply constraints were "not ...

The drug semaglutide is already proving incredibly effective in tackling diabetes (under the brand name Ozempic) and weight loss (as Wegovy), and a new study suggests it can do wonders for a type of ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.